Tamoxifen
Two tamoxifen products sit on this shelf: Nolvadex, available at 10 mg and 20 mg, and Tamoxifen Tablets at 20 mg. Both are tablets listed for breast cancer.
Tamoxifen Tablets
Breast Cancer
20mg
Tamoxifen tablets for breast cancer. It blocks oestrogen that some breast cancers rely on to grow.
From$1.00/ tabletView
Key points
- Tamoxifen is an antioestrogen: it blocks oestrogen from binding to receptors in breast tumour tissue, which slows or stops the growth of hormone-sensitive cancers.
- The label carries a boxed warning for women using tamoxifen to reduce breast cancer risk: uterine malignancies, stroke and pulmonary embolism have been reported, and some were fatal. In women already diagnosed with breast cancer, the benefits outweigh these risks.
- Do not take tamoxifen citrate if you have a history of deep-vein thrombosis or pulmonary embolism, or if you need coumarin-type anticoagulant therapy alongside it.
Common questions about Tamoxifen
What separates Nolvadex from Tamoxifen Tablets on this shelf?
Nolvadex is the original brand and comes in both 10 mg and 20 mg strengths. Tamoxifen Tablets is the generic version, listed at 20 mg only. Both contain tamoxifen citrate as the active ingredient and fall under Oncology Support.
Does tamoxifen affect cholesterol or bone density?
In postmenopausal women, tamoxifen reduces total cholesterol and low-density lipoprotein levels by around 10 to 20%. It does not adversely affect bone mineral density, which sets it apart from some other hormonal treatments that thin the bones.